Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX)
On this news, Novavaxs stock price fell $15.50 per share, or 8.81%, to close at $160.50 per share on May 10, 2021.
- On this news, Novavaxs stock price fell $15.50 per share, or 8.81%, to close at $160.50 per share on May 10, 2021.
- The stock price continued to decline $22.32 per share, or 13.91%, to close at $138.18 per share on May 11, 2021, thereby injuring investors.
- To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
- Glancy Prongay & Murray LLP, Los Angeles